Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Preventive Healthcare Services01:30

Preventive Healthcare Services

1.0K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.0K
Cancer Survival Analysis01:21

Cancer Survival Analysis

345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Tumor Progression02:07

Tumor Progression

6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Cancer Vaccines01:30

Cancer Vaccines

363
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
363
Levels of Health Promotion and Illness Prevention01:26

Levels of Health Promotion and Illness Prevention

12.6K
Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
12.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The impact of an organized screening program on gastric cancer incidence: a quasi-experimental study.

International journal of epidemiology·2026
Same author

Combination of a 19-gauge needle and 0.018-inch guidewire with a Y-connector during endoscopic ultrasound-guided hepaticogastrostomy.

VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy·2022
Same author

Time-series multispectral imaging in soybean for improving biomass and genomic prediction accuracy.

The plant genome·2022
Same author

MAFLD associated with COPD via systemic inflammation independent of aging and smoking in men.

Diabetology & metabolic syndrome·2022
Same author

Impact of the COVID-19 pandemic on the diagnosis of cancer in Japan: analysis of hospital-based cancer registries.

Japanese journal of clinical oncology·2022
Same author

[COVID-19-induced changes in the treatment and hospital visits of cancer patients].

[Nihon koshu eisei zasshi] Japanese journal of public health·2022
Same journal

Cost-benefit analysis of an organized community-based multi-cancer screening program in Bangladesh.

Journal of medical screening·2026
Same journal

Response to: Adjusting for non-compliance and contamination with a more plausible assumption.

Journal of medical screening·2026
Same journal

Response to Takahashi regarding Bestwick and Wald: Mischaracterisation of evidence in prostate cancer screening.

Journal of medical screening·2026
Same journal

No-cost envelope modification improves fecal immunochemical test laboratory acceptance in a US Veterans Affairs colorectal cancer screening trial.

Journal of medical screening·2026
Same journal

Prostate cancer screening: The level of the evidence hierarchy.

Journal of medical screening·2026
Same journal

Prediction model to prioritize colorectal cancer screening with visual colonoscopy.

Journal of medical screening·2026
See all related articles

Related Experiment Video

Updated: Jun 29, 2025

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format
05:58

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format

Published on: August 20, 2018

10.9K

Cancer screening programs in Japan: Progress and challenges.

Chisato Hamashima1,2, Hirokazu Takahashi2

  • 1Health Policy Section, Department of Nursing, Faculty of Medical Technology, Teikyo University, Tokyo, Japan.

Journal of Medical Screening
|March 28, 2024
PubMed
Summary
This summary is machine-generated.

Japan offers national cancer screening programs, but participation rates for breast and cervical cancers lag behind OECD averages. Enhancing evidence-based guidelines and quality assurance is crucial for improving screening effectiveness.

Keywords:
Cancer screeningcancer mortalityevidence-based guidelinesparticipation ratequality assurance

More Related Videos

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
07:49

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study

Published on: April 18, 2025

158
Lung Tumor Cell Recruitment Assay
04:28

Lung Tumor Cell Recruitment Assay

Published on: February 26, 2019

5.3K

Related Experiment Videos

Last Updated: Jun 29, 2025

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format
05:58

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format

Published on: August 20, 2018

10.9K
Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
07:49

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study

Published on: April 18, 2025

158
Lung Tumor Cell Recruitment Assay
04:28

Lung Tumor Cell Recruitment Assay

Published on: February 26, 2019

5.3K

Area of Science:

  • Public Health
  • Oncology
  • Health Services Research

Background:

  • Japan has established national screening programs for major cancers including gastric, colorectal, lung, breast, and cervical cancers.
  • Cancer screening guidelines have been developed and updated since 2003, promoting evidence-based practices.
  • Current screening delivery primarily occurs through community and workplace initiatives.

Purpose of the Study:

  • To evaluate the current state of national cancer screening programs in Japan.
  • To identify challenges and areas for improvement in cancer screening delivery and participation.
  • To highlight the need for enhanced evidence-based practices and quality assurance systems.

Main Methods:

  • Analysis of existing national screening programs and guidelines for various cancers.
  • Comparison of participation rates with Organisation for Economic Co-operation and Development (OECD) countries.
  • Assessment of data collection methods for participation rates, including reliance on surveys due to lack of national registries.
  • Review of quality assurance systems for community and workplace screening.

Main Results:

  • Participation rates for breast and cervical cancer screening are lower compared to the OECD average.
  • Accurate calculation of participation rates is hindered by the absence of comprehensive national cancer screening registries.
  • Quality assurance systems were historically limited to community-based screening and only recently adapted for workplace settings.

Conclusions:

  • The complex delivery system of cancer screening programs may impede higher participation rates.
  • Continued efforts are required to strengthen evidence-based screening recommendations.
  • Establishing a robust and comprehensive national quality assurance system is essential for improving cancer screening effectiveness in Japan.